“Retrospective Comparison of Efficacy and Safety of Basiliximab and Antithymocyte Globulin in Kidney Transplant Recipients”. Khartoum Journal of Pharmaceutical Sciences, vol. 1, no. 1, Aug. 2021, https://doi.org/10.53332/kjps.v1i1.40.